Moderna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sk Telecom (SKM) call put ratio 1.7 calls 1 put on 9900 contracts
- Freeport-McMoran (FCX) call put ratio 1.5 calls 1 put amid copper near all-time high
- Amgen (AMGN) call put ratio 1 call 1 put
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
